Log-in here if you’re a member with access to the Closer.

Looking for deeper insight on markets?  In tonight’s Closer sent to Bespoke Institutional clients, we start off with a quick comment on Moderna (MRNA) reaching the required number of cases for an initial efficacy analysis for their COVID-19 vaccine and how the VIX curve is looking with this news. We then take a look at the massive moves on a sector basis and some strong readings across breadth indicators.  We close things out with a review of this week’s ICI fund flow data.

See today’s post-market Closer and everything else Bespoke publishes by starting a 14-day free trial to Bespoke Institutional today!

Print Friendly, PDF & Email